Drug intelligence / Profile preview

Pulmotin

Development stage
Unknown
Lead developer
Serumwerk Bernburg
Modality
Small Molecules
Administration
Topical, Inhalation
01

Overview

Pulmotin is a topical cold ointment developed and manufactured by Serum-Werk Bernburg. It is indicated for the relief of symptoms associated with respiratory tract colds, such as coughs, hoarseness, and bronchial congestion. The formulation consists of a combination of essential oils and aromatic compounds, specifically eucalyptus oil, camphor, and thymol. These active ingredients function through the inhalation of volatile vapors and local absorption through the skin. Pulmotin exerts secretolytic and expectorant effects, helping to liquefy bronchial mucus and facilitate its removal. Additionally, it promotes local blood circulation (hyperemia) and possesses mild antiseptic properties, providing symptomatic relief for both adults and children.

Brand names
PulmotinPulmotin Erkältungssalbe
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Pulmotin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmotin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call